v3.26.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Total revenue $ 235 $ 1,364 $ 235 $ 1,620
Operating expenses:        
Research and development 3,891 7,141 16,243 12,282
Selling, general and administrative 4,119 3,784 8,707 7,528
Total operating expenses 8,010 10,925 24,950 19,810
Loss from operations (7,775) (9,561) (24,715) (18,190)
Other (income) expense:        
Amortization of debt issuance costs and discount 0 0 0 312
Interest income (685) (510) (1,168) (1,305)
Interest expense 0 0 0 173
Other income (335) 0 (742) 0
Warrant liabilities fair value adjustment (14,152) (2,166) (8,903) (5,094)
Total other income (15,172) (2,676) (10,813) (5,914)
Net income (loss) $ 7,397 $ (6,885) $ (13,902) $ (12,276)
Net income (loss) per share - basic $ 0.63 $ (1.11) $ (1.53) $ (1.98)
Net income (loss) per share - diluted $ 0.63 $ (1.11) $ (1.53) $ (1.98)
Weighted average common shares outstanding - basic 11,824,078 6,218,614 9,115,078 6,199,235
Weighted average common shares outstanding - Diluted 11,824,078 6,218,614 9,115,078 6,199,235
License Agreement Revenue        
Revenue:        
Total revenue $ 235 $ 1,364 $ 235 $ 1,620